Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Pseudoephedrine)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST001639 AN002681 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort Blood Human COPD National Jewish Health AU
ST001403 AN002345 Ontogeny related changes in the pediatric liver metabolome (part-II) Liver Human Moffitt Cancer Center estimated abundances
ST001940 AN003155 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001940 AN003156 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001940 AN003157 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001940 AN003158 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001844 AN002987 Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part III) Blood Human Fatty liver disease University of California, Davis normalized peak height
ST001844 AN002987 Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part III) Liver Human Fatty liver disease University of California, Davis normalized peak height
ST002027 AN003297 Metabolomics Analysis of Blood Plasma and Stool from Six Week Flaxseed Dietary Intervention in Postmenopausal Women (Serum/HILIC) Blood Human UC Davis normalized peak height
ST000241 AN000373 Cyclobutene- and cyclobutane-functionalized fatty acids as novel biochemical probes of structure and function in HepG2 cells Cultured cells Human University of Nebraska-Lincoln Peak area
ST001720 AN002803 Metabolomics Analysis of ACTG Cohort -Update (part-II) Blood Human HIV The Wistar Institute Peak area
ST001211 AN002017 Metabolomic Markers of Methotrexate Response, In Vitro Cultured cells Human University Of Kansas Peak height
ST001815 AN002945 Metabolic Markers of Methotrexate Response in Juvenile Idiopathic Arthritis Blood Human Arthritis University Of Kansas Peak Height Intensity
ST000899 AN001462 Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling Blood Human Inflammatory bowel disease Vanderbilt University Medical Center raw area counts
ST002819 AN004590 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) Blood Human Tufts Medical Center raw area counts rescaled to set the median equal to 1
ST002820 AN004594 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (AASKG1) Blood Human Tufts Medical Center raw area counts rescaled to set the median equal to 1
ST002094 AN003421 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic raw intensity
ST001404 AN002346 Ontogeny related changes in the pediatric liver metabolome (part-III) Liver Human Moffitt Cancer Center Relative Abundance
ST002088 AN003406 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema Blood Human COPD National Jewish Health relativeMedian
ST002089 AN003410 Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. Blood Human COPD National Jewish Health relativeMedian
  logo